Edaravone Powder is a new free radical scavenger, which is suitable for improving the neurological abnormalities caused by acute cerebral infarction. Because its molecular structure contains lipophilic groups, it can easily reach the brain tissue through the blood-brain barrier, and it has a protective effect on nerve cell damage caused by cerebral ischemia. In addition to its own Medical capability, Hot sales Edaravone is also an intermediate for the synthesis of various pharmaceutical and chemical raw materials, such as dyes such as Mordant Bordeaux BN, Permanent yellow G and Leather spray red G, and reagents for the determination of cobalt, copper, iron, nickel, silver and vitamin B12.
| Molecular formula |
|
|
|
Item |
Standard |
Test Results |
|
Appearance |
White powder |
Conforms |
|
Identification (IR) |
Concordant with reference spectrum |
Conforms |
|
Assay |
≥99.0% |
99.2% |
|
Water |
<2.0% |
0.4% |
|
Residual solvent |
<1.0% |
0.2% |
|
Heavy Metals |
≤15 |
10 |
|
Loss on Drying |
≤0.3% |
0.04% |
|
Residue on Ignition |
≤0.3% |
0.08% |
|
Chromatographic purity |
Meets the requirements |
Conforms |
|
Organic volatile impurities |
Meets the requirements |
Conforms |
|
Microbial assessment |
Compliance with indicators |
Conforms |
|
BSE |
not detected |
not detected |
|
GMO |
not detected |
not detected |
|
Allergen |
not detected |
not detected |
|
Radiation |
not detected |
not detected |
|
Conclusion: |
Conform with enterprise specification . |
What is the mechanism of action of this product?
The mechanism of Edaravone's neuroprotective effect on nerve cells mainly involves clearing oxygen free radicals, inhibiting lipid peroxidation, regulating inflammatory factors, thereby inhibiting brain cell apoptosis, oxidative damage to vascular endothelial cells and nerve cells, etc. Clinical studies suggest that N-acetylaspartic acid (NAA) is a specific marker of surviving nerve cells, and its content decreases sharply in the early stages of cerebral infarction. If appropriate Edaravone powder is given during the acute phase of cerebral infarction, it can inhibit the reduction of local cerebral blood flow around the infarction, resulting in a significant increase in NAA content in the brain on the 28th day after onset compared to the glycerol control group. In animal experiments, we have found that administering Edaravone to rats under ischemia can prevent the progression of cerebral edema and infarction, alleviate accompanying neurological symptoms, and inhibit delayed neuronal death.
What is the market prospect of this product?
Among numerous neurological products, edaravone is currently the only neuroprotective agent with sufficient evidence-based medicine. The Phase III clinical trial conducted in Japan has confirmed that edaravone can effectively improve patients' neurological function prognosis. This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial with a high level of evidence. The "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke (2014 Edition)" states that edaravone is an antioxidant and free radical scavenger. Multiple randomized double-blind placebo-controlled trials at home and abroad have suggested that edaravone can improve the functional outcomes of acute cerebral infarction and is safe (Level I recommendation, Level B evidence). The "Japanese Stroke Treatment Guidelines 2015" published in 2017 pointed out that edaravone (an antioxidant drug) can effectively improve the prognosis of patients with acute cerebral infarction (within 72 hours of onset). Stratified analysis showed that edaravone has better efficacy in patients with cerebral infarction within 24 hours of onset, and therefore has been approved for use in Japan (level 2, with only alteplase and aspirin recommended at level 1), and edaravone powder is the only recommended neuroprotective agent in this guideline. Europe is currently conducting Phase 2 clinical trials.
A variety of shipping methods for you to choose
|
Transportation Time |
Shipping method |
Cargo weight requirements |
Advantage |
|
3-7 days |
DHL,Germany DHL,Germany DPD, |
Suitable for under 50kg. |
We have warehouses in Germany and California, USA, |
|
7-15 days |
By Air |
Suitable for more than 50kg. |
|
|
15-60 days |
By Sea |
Suitable for more than 500kg. |
Our strengths:
Our company has passed FDA and ISO19001 quality management system certification. And we have internal cooperation agreements with multiple factories and laboratories in China,Our company can provide Edaravone Powder etc. at a more favorable price. If you are interested, please leave a message.
We not only have unique advantages in transportation, but also support multiple payment methods, whether you use US dollars, euros, Australian dollars, or local currencies from Singapore, Malaysia, Thailand, and so on. We can also support local currencies in these regions and countries. In addition, we also support bank cards (credit cards, etc.) for payments.
Disclaimer: The information published on this website comes from the internet, which does not mean that this website agrees with its views or confirms the authenticity of the content. Please pay attention to distinguish it. In addition, the products provided by our company are only used for scientific research. We are not responsible for the consequences of any improper use.
If you are interested in our products, or have critical suggestions on our articles or are not completely satisfied with the products received, please contact us by Email :sales6@faithfulbio.com . Our team is committed to ensuring the complete satisfaction of customers.
Hot Tags: edaravone powder cas 89-25-8, China, suppliers, manufacturers, factory, customized, wholesale, buy, price, bulk, pure, producer, discount, for sale, in stock, free sample, raw powder, raw material, made in China







